| Literature DB >> 25278315 |
Eric Chamot1, Ilya Kister, Gary R Cutter.
Abstract
BACKGROUND: The eight Performance Scales and three assimilated scales (PS) used in North American Research Committee on Multiple Sclerosis (NARCOMS) registry surveys cover a broad range of neurologic domains commonly affected by multiple sclerosis (mobility, hand function, vision, fatigue, cognition, bladder/bowel, sensory, spasticity, pain, depression, and tremor/coordination). Each scale consists of a single 6-to-7-point Likert item with response categories ranging from "normal" to "total disability". Relatively little is known about the performances of the summary index of disability derived from these scales (the Performance Scales Sum or PSS). In this study, we demonstrate the value of a combination of classical and modern methods recently proposed by the Patient-Reported Outcome Measurement Information System (PROMIS) network to evaluate the psychometric properties of the PSS and derive an improved measure of global disability from the PS.Entities:
Mesh:
Year: 2014 PMID: 25278315 PMCID: PMC4195863 DOI: 10.1186/s12883-014-0192-1
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Figure 1Unidimensional CFA model of self-assessed neurological disability in NARCOMS registrants. Note: “Disability” represents a latent factor, i.e., a not directly observable continuous variable whose scale is inferred from the variability and correlations among PS. “PS-factor correlations” are estimates of the correlations between PS and factor scores. “Residual variances” represent the fractions of PS score variability that are not explained by the factor.
Figure 2Bifactor CFA model of self-assessed neurological disability in NARCOMS registrants. Note: “Global” represents the general factor of global disability; “Physical” and “Mental” represent the auxiliary factors of “physical” and “mental” disability. Correlations among the three factors are all forced to be zero. Thus, the physical and mental factors each explain a fraction of the variability in PS scores left unexplained by the general factor. Comparisons of “Residual variances” in Figure 2 and Figure 1, provide information about the fraction of variability in PS scores that the two auxiliary factors explain above and beyond the general factor.
Figure 3Relation among Performance Scale (PS) categories, Performance Scales Sum (PSS-11) scores and PS IRT scores of global disability (from unidimensional model) in a sample of NARCOMS registrants.
Figure 4Relations among the levels of the Performance Scales Sum (PSS-11) score and the IRT summed score of global disability. Note: To facilitate comparisons, the levels of the IRT summed score were linearly transformed to range from 0 to 46 (i.e., the range of the PSS-11 levels). Thus, had the levels of the two scores been perfectly equivalent, then the dots on the figure would have been aligned on the diagonal line.
Figure 5Associations between Performance Scales-based, IRT-derived, scores of disability and PDDS scores in a sample of NARCOMS registrants. a) Scores of global disability generated from the bifactor IRT model (●) versus the unidimensional IRT model (□, pattern scores; ▲, summed scores). b) Scores of residual physical disability generated from the bifactor IRT model. c) Scores of residual mental disability generated from the bifactor IRT model. Note: Although the scores of global disability, residual physical disability, and residual mental disability are all reported as scaled scores (Mean, 50; SD, 15), they are not on the same metric. Error bars represent 95% confidence intervals. Spearman correlations between IRT scores and PDDS scores: Figure 5a) ● 0.60, □ 0.65, ▲0.68; Figure 5b) 0.72; Figure 5c) 0.07.
Performance Scales-based, IRT-derived, scaled scores of disability by patient characteristics
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
|
|
|
|
|
| ||
| Age at assessment (y.) | ||||||
| ≤ 35 | 749 (19.1) | 45.2 (44.1, 46.2)*** | 44.6 (43.6, 45.7)*** | 44.5 (43.5, 45.6)*** | 42.5 (41.7, 43.4)*** | 41.2 (40.2, 42.2)*** |
| 36 – 55 | 1760 (44.8) | 50.3 (49.6, 51.0) | 50.1 (49.4, 50.8) | 50.0. (49.3, 50.7) | 47.8 (47.1, 48.4) | 47.4 (46.6, 48.2) |
| ≥ 56 | 1417 (36.1) | 52.2 (51.5, 53.0) | 52.7 (52.0, 53.5) | 52.9 (52.2, 53.7) | 56.7 (55.9, 57.5) | 57.9. (57.0, 58.8) |
| Disease duration (y.) | ||||||
| ≤ 10 | 1713 (43.6) | 46.2 (45.5, 46.9)*** | 45.7 (45.0, 46.5)*** | 45.5 (44.8, 46.2)*** | 45.2 (44.5, 45.8)*** | 44.3 (43.6, 45.0)*** |
| 11 – 20 | 1109 (28.3) | 51.7 (50.9, 52.6) | 51.8 (51.0, 52.7) | 51.9 (51.1, 52.7) | 50.6 (49.7, 51.5) | 50.7 (49.7, 51.7) |
| ≥ 21 | 1104 (28.1) | 54.2 (53.3, 55.0) | 54.8 (54.0, 55.6) | 55.1 (54.3, 55.9) | 56.9 (56.0, 57.8) | 58.2 (57.1, 59.2) |
| Gender | ||||||
| Female | 3102 (79.4) | 49.7 (49.2, 50.2)** | 49.6 (49.1, 50.1)*** | 49.5 (49.0, 50.0)*** | 48.8 (48.3, 49.3)*** | 48.5. (47.9, 49.1)*** |
| Male | 803 (20.6) | 51.3 (50.2 52.4) | 51.6 (50.5, 52.7) | 51.9 (50.8, 53.0) | 54.8 (53.7, 55.9) | 55.6 (54.4, 56.9) |
| Race/Ethnicity | ||||||
| White | 3491 (90.2) | 49.8 (49.3, 50.3)*** | 49.8 (49.3, 50.3)*** | 49.7 (49.3, 50.2)*** | 50.0 (49.5, 50.5)* | 50.0 (49.4, 50.6)* |
| African American | 132 (3.4) | 50.7 (48.2, 53,2) | 51.0 (48.6, 53.4) | 51.5 (49.0, 54.0) | 51.8 (49.0, 54.5) | 52.1 (48.9, 55.3) |
| Hispanic/Latino | 120 (3.1) | 48.1. (45.2, 51.0) | 47.9 (45.0, 50.8) | 47.8 (44.8, 50.5) | 46.5 (43.8, 49.2) | 45.9. (42.7, 49.1) |
| Native American | 76 (2.0) | 56.7 (53.3, 60.1) | 56.6 (53.2, 59.9) | 56.7 (53.3, 60.1) | 48.3 (45.6, 51.1) | 48.0 (44.8, 51.3) |
| Other | 49 (1.3) | 53.4 (48.5, 58.1) | 53.1 (48.3, 57.9) | 53.3 (48.4, 58.3) | 47.3. (43.6, 51.0) | 46.8. (42.4, 51.2) |
| Disease modifying therapy | ||||||
| Yes | 2614 (66.6) | 49.2. (48.6, 49.8)*** | 49.2 (48.6, 49.7)*** | 49.1 (48.5, 49.7)*** | 48.8. (48.2, 49.3)*** | 48.6 (47.0, 49.2)*** |
| No | 1312 (33.4) | 51.6 (50.8, 52.4) | 51.7 (50.8, 52.5) | 51.8 (51.0, 52.7) | 52.4 (51.5, 53.3) | 55.6 (54.4, 56.9) |
| Year of assessment | ||||||
| 2003-2005 | 1640 (41.8) | 50.0 (49.2, 50.7)** | 50.3 (49.5, 51.0)* | 50.6 (49.8, 51.3)* | 51.1 (50.4, 51.9)*** | 51.3 (50.4, 52.2)*** |
| 2006-2008 | 957 (24.4) | 48.9 (47.9, 49.8) | 49.0 (48.0, 49.9) | 49.0 (48.1, 50.0) | 49.1 (48.1, 50.0) | 48.9 (47.7, 50.0) |
| 2009-2011 | 1329 (33.8) | 50.8 (50.0, 51.6) | 50.4 (49.6, 51.2) | 50.0 (49.2, 50.8) | 49.3 (48.5, 50.1) | 49.2 (48.3, 50.1) |
aPattern stands for Bayesian Expected a Posteriori (EAP) score; as many different score estimates were produced for each raw PSS score as the number of item response combinations yielding the PSS score.
bSummed stands for EAP Summed Score; only one summary EAP Summed Score was generated for each raw PSS score.
*P < 0.05; **P < 0.01; ***P < 0.001.
Note. The scores of global disability, residual physical disability, and residual mental disability are all reported as scaled scores (S) with mean 50 and SD 15, but they are not on the same metric. All the scores of global disability are directly comparable, but not the scores of residual physical disability and residual mental disability. For instance, because the SD of the score of global disability is much larger than that of the scores of physical and mental disability, a score of global disability of S = 70 represents much more disability than a score of residual physical, or mental, disability of S = 70.
Figure 6Relations between distributions of Performance Scales IRT scores (left) and raw Performance Scales Sum (PSS-11) scores (right) among employed and unemployed NARCOMS registrants. Note: Data on causes of unemployment were not available.
Associations between IRT-derived disability scores and prevalence of unemployment after adjustment for patient characteristics
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
| Global disability (scaled score, S)b | ||||
| S ≤ 33.3 | 562 (14.3) | 1.0c,d | 1.0c,d | 1.0c,e |
| 33.3 < S ≤ 50 | 1390 (35.4) | 1.50 (1.28, 1.77) | 1.83 (1.55, 2.17) | 1.73 (1.46, 2.04) |
| 50 < S ≤ 66.7 | 1428 (36.4) | 2.14 (1.83, 2.51) | 2.75 (2.34, 3.23) | 2.87 (2.46, 3.36) |
| S > 66.7 | 546 (13.9) | 2.74 (2.33, 3.22) | 3.66 (3.12, 4.30) | 3.79 (3.24, 4.43) |
| Residual physical disability (scaled score, S)b | ||||
| S ≤ 33.3 | 257 (6.5) | 1.0c,d | ||
| 33.3 < S ≤ 50 | 1876 (47.8) | 1.17 (.99, 1.38) | ||
| 50 < S ≤ 66.7 | 1339 (34.1) | 1.56 (1.32, 1.84) | ||
| S > 66.7 | 454 (11.6) | 2.02 (1.70, 2.40) | ||
| Residual mental disability (scaled score, S)b | ||||
| S ≤ 33.3 | 236 (6.0) | 1.0c,d | ||
| 33.3 < S ≤ 50 | 1678 (42.7) | 1.11 (.98, 1.26) | ||
| 50 < S ≤ 66.7 | 1783 (45.5) | 1.35 (1.19, 1.52) | ||
| S > 66.7 | 229 (5.8) | 1.53 (1.32, 1.78) | ||
| Disease duration (y.) | ||||
| ≤ 10 | 1713 (43.6) | 1.0c | 1.0c | 1.0c |
| 11 – 20 | 1109 (28.3) | 1.06 (.98, 1.14) | 1.10 (1.02, 1.19) | 1.09 (1.01, 1.18) |
| ≥ 21 | 1104 (28.1) | 1.21 (1.13, 1.30) | 1.27 (1.18, 1.37) | 1.25 (1.16, 1.34) |
| Age at assessment (y.) | ||||
| ≤ 35 | 749 (19.1) | 1.0c | 1.0c | 1.0c |
| 36 – 55 | 1760 (44.8) | 1.01 (.91, 1.11) | 1.03 (.93, 1.14) | 1.02 (.92, 1.13) |
| ≥ 56 | 1417 (36.1) | 1.22 (1.10, 1.35) | 1.31 (1.18, 1.45) | 1.28 (1.16, 1.42) |
| Gender | ||||
| Female | 3102 (79.4) | 1.0c | 1.0c | 1.0c |
| Male | 803 (20.6) | 1.04 (.98, 1.10) | 1.08 (1.02, 1.15) | 1.08 (1.01, 1.14) |
| Race/Ethnicity | ||||
| White | 3491 (90.2) | 1.0c | 1.0c | 1.0c |
| African American | 132 (3.4) | 1.14 (.99, 1.31) | 1.16 (1.00, 1.33) | 1.14 (.99, 1.31) |
| Hispanic/Latino | 120 (3.1) | 1.14 (.97, 1.34) | 1.11 (.95, 1.31) | 1.12 (.94, 1.31) |
| Native American | 76 (2.0) | 1.11 (.95, 1.30) | 1.10 (.95, 1.28) | 1.09 (.94, 1.25) |
| Other | 49 (1.3) | 1.23 (1.00, 1.52) | 1.24 (1.00, 1.52) | 1.16 (.94, 1.43) |
| Disease modifying therapy | ||||
| Yes | 2614 (66.6) | 1.0c | 1.0c | 1.0c |
| No | 1312 (33.4) | 1.05 (.99, 1.11) | 1.08 (1.02, 1.14) | 1.06 (1.01, 1.13) |
| Year of assessment | ||||
| 2003-2005 | 1640 (41.8) | 1.0c | 1.0c | 1.0c |
| 2006-2008 | 957 (24.4) | 1.01 (.94, 1.08) | 1.01 (.94, 1.09) | 1.02 (.95, 1.09) |
| 2009-2011 | 1329 (33.8) | 1.04 (.98, 1.11) | 1.01 (.94, 1.07) | 1.01 (.95, 1.08) |
aPR stands for “prevalence ratio”. Because prevalence of unemployment was high, we performed Poisson regression with robust variance estimation instead of logistic regression to obtain unbiased prevalence ratio estimates [30].
bIRT scores scaled to have mean 50 and SD 15 in the NARCOMS sample.
cReference category.
dBayesian Expected a posteriori (EAP) estimates of disability (i.e., “IRT pattern scores”).
eEAP summed-score estimates of disability (i.e., “IRT summed scores”).